EMIM 2018 ControlCenter

Online Program Search result for ”keyword:"pretargeting"“ - 3 matches

To search for a specific ID please enter the hash sign followed by the ID number (e.g. #123).

# 191 – Antibody conjugation with trans-cyclooctene and Desferoxamine to enable in vivo click reaction for pretargeting strategies (#178)

I. V. J. Feiner1, V. Gómez-Vallejo1, J. Calvo2, J. Llop1

Session: PW-21 - New Probes | Synthesis and Enabling Technologies II
Date: Friday, 23 March, 2018, 11:30 AM
Room: Banquet Hall | level -1 (Banquet Hall)

PS-18-3 – Caveolin-1 inhibition increases and accelerates 89Zr-trastuzumab uptake in HER2-positive tumours: preclinical studies in tumour xenografts and human tumours (#191)

P. M. R. Pereira1, K. J. Edwards1, L. M. Carter1, J. - P. Meyer1, J. Pourat1, J. C. Durack1, J. S. Lewis1

Session: PS-18 - Oncology: Solutions to unmet Clinical Need
Date: Thursday, 22 March, 2018, 4:00 PM
Room: Lecture Room 02 | level -1 (Room 02)

# 257 – Development and validation of a pretargeting strategy for radio-immunotherapy with novel 188Re-labelled vector molecules. (#553)

T. Van Royen1, C. Vanhove2, F. De Vos1

Session: PW-28 - Oncology | Solutions to unmet clinical need
Date: Friday, 23 March, 2018, 11:30 AM
Room: Banquet Hall | level -1 (Banquet Hall)